ClinicalTrials.govpublic full text
Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment
hypercholesterolemia, ldl-c apheresis, elevated cholesterol, high cholesterol, pcsk9 mutations, severe familial hypercholesterolemia, evolocumab, repatha, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 859734
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.